Clinical features and APOE genotype of pathologically proven early-onset Alzheimer disease

Neurology

Volumn 76, Issue 20, 2011, Pages 1720-1725

  Balasa, M ^a   Gelpi, E ^b   Antonell, A ^a   Rey, M J ^b   Sanchez Valle R ^a   Molinuevo, J L ^a   Llado A ^a  

^a HOSPITAL CLÍNIC   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E;

ADULT; ALZHEIMER DISEASE; ANTEROGRADE AMNESIA; ARTICLE; BEHAVIOR DISORDER; CLINICAL ARTICLE; CLINICAL FEATURE; CORTICOBASAL DEGENERATION; DELAYED DIAGNOSIS; DEMENTIA; DEPRESSION; DIAGNOSTIC ERROR; DISEASE DURATION; EARLY ONSET ALZHEIMER DISEASE; EXECUTIVE FUNCTION; FEMALE; FRONTOTEMPORAL DEMENTIA; GENE FREQUENCY; GENETIC CORRELATION; GENOTYPE; HUMAN; HUMAN TISSUE; MALE; NEUROPATHOLOGY; NORMOTENSIVE HYDROCEPHALUS; ONSET AGE; PREVALENCE; PRIMARY PROGRESSIVE APHASIA; PRIORITY JOURNAL; PSEUDODEMENTIA; SEMANTIC DEMENTIA;

AGE OF ONSET; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; APOLIPOPROTEINS E; AUTOPSY; BRAIN; COGNITION; DELAYED DIAGNOSIS; DNA; FEMALE; GENOTYPE; HUMANS; LEWY BODIES; MALE; MEMORY DISORDERS; MIDDLE AGED; PHENOTYPE; PRESENILIN-1; PRESENILIN-2; RETROSPECTIVE STUDIES; TISSUE BANKS;

EID: 79957531921     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e31821a44dd     Document Type: Article

References (32)

1. Garre-Olmo J, Genis Batlle D, del Mar Fernandez M, et al. Incidence and subtypes of early-onset dementia in a geographically defined general population. Neurology 2010;75:1249-1255.
2. Harvey RJ, Skelton-Robinson M, Rossor MN. The prevalence and causes of dementia in people under the age of 65 years. J Neurol Neurosurg Psychiatry 2003;74:1206-1209.
3. Petersen RC. Clinical subtypes of Alzheimer's disease. Dement Geriatr Cogn Disord 1998;9(suppl 3):16-24. (Pubitemid 28479330)
4. Stopford CL, Snowden JS, Thompson JC, Neary D. Variability in cognitive presentation of Alzheimer's disease. Cortex 2008;44:185-195. (Pubitemid 351729233)
5. Galton CJ, Patterson K, Xuereb JH, Hodges JR. Atypical and typical presentations of Alzheimer's disease: a clinical, neuropsychological, neuroimaging and pathological study of 13 cases. Brain 2000;123:484-498. (Pubitemid 30099534)
6. Alladi S, Xuereb J, Bak T, et al. Focal cortical presentations of Alzheimer's disease. Brain 2007;130:2636-2645. (Pubitemid 47511719)
7. Licht EA, McMurtray AM, Saul RE, Mendez MF. Cognitive differences between early- and late-onset Alzheimer's disease. Am J Alzheimers Dis Other Demen 2007;22: 218-222. (Pubitemid 47025521)
8. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34: 939-944. (Pubitemid 14076461)
9. Braak H, Braak E. Diagnostic criteria for neuropathologic assessment of Alzheimer's disease. Neurobiol Aging 1997; 18:S85-S88. (Pubitemid 27454703)
10. The National Institute on Aging, and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's Disease. Consensus recommendations for the postmortem diagnosis of Alzheimer's disease. Neurobiol Aging 1997;18:S1-S2.
11. Alafuzoff I, Arzberger T, Al-Sarraj S, et al. Staging of neurofibrillary pathology in Alzheimer's disease: a study of the BrainNet Europe Consortium. Brain Pathol 2008;18: 484-496.
12. Alafuzoff I, Thal DR, Arzberger T, et al. Assessment of beta-amyloid deposits in human brain: a study of the BrainNet Europe Consortium. Acta Neuropathol 2009; 117:309-320.
13. Alafuzoff I, Ince PG, Arzberger T, et al. Staging/typing of Lewy body related alpha-synuclein pathology: a study of the BrainNet Europe Consortium. Acta Neuropathol 2009;117:635-652.
14. Koedam EL, Lauffer V, van der Vlies AE, van der Flier WM, Scheltens P, Pijnenburg YA. Early-versus late-onset Alzheimer's disease: more than age alone. J Alzheimers Dis 2010;19:1401-1408.
15. Gass J, Cannon A, Mackenzie IR, et al. Mutations in progranulin are a major cause of ubiquitin-positive frontotemporal lobar degeneration. Hum Mol Genet 2006;15: 2988-3001. (Pubitemid 44530703)
16. Blennow K, Hampel H. CSF markers for incipient Alzheimer's disease. Lancet Neurol 2003;2:605-613. (Pubitemid 37162569)
17. Klunk WE, Engler H, Nordberg A, et al. Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B. Ann Neurol 2004;55:306-319. (Pubitemid 38269583)
18. Dubois B, Feldman HH, Jacova C, et al. Revising the definition of Alzheimer's disease: a new lexicon. Lancet Neurol 2010;9:1118-1127.
19. Taylor KI, Probst A, Miserez AR, Monsch AU, Tolnay M. Clinical course of neuropathologically confirmed frontalvariant Alzheimer's disease. Nat Clin Pract Neurol 2008;4: 226-232. (Pubitemid 351516750)
20. Neary D, Snowden JS, Gustafson L, et al. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology 1998;51:1546-1554.
21. Benson DF, Davis RJ, Snyder BD. Posterior cortical atrophy. Arch Neurol 1988;45:789-793.
22. Renner JA, Burns JM, Hou CE, McKeel DW Jr, Storandt M, Morris JC. Progressive posterior cortical dysfunction: a clinicopathologic series. Neurology 2004;63:1175-1180. (Pubitemid 39350013)
23. Tang-Wai DF, Graff-Radford NR, Boeve BF, et al. Clinical, genetic, and neuropathologic characteristics of posterior cortical atrophy. Neurology 2004;63:1168-1174. (Pubitemid 39350012)
24. Aharon-Peretz J, Israel O, Goldsher D, Peretz A. Posterior cortical atrophy variants of Alzheimer's disease. Dement Geriatr Cogn Disord 1999;10:483-487. (Pubitemid 29512016)
25. Ross SJ, Graham N, Stuart-Green L, et al. Progressive biparietal atrophy: an atypical presentation of Alzheimer's disease. J Neurol Neurosurg Psychiatry 1996;61:388-395. (Pubitemid 26355781)
26. Ling H, O'Sullivan SS, Holton JL, et al. Does corticobasal degeneration exist? A clinicopathological re-evaluation. Brain 2010;133:2045-2057.
27. Gorno-Tempini ML, Brambati SM, Ginex V, et al. The logopenic/phonological variant of primary progressive aphasia. Neurology 2008;71:1227-1234.
28. Rabinovici GD, Jagust WJ, Furst AJ, et al. Abeta amyloid and glucose metabolism in three variants of primary progressive aphasia. Ann Neurol 2008;64:388-401.
29. Farrer LA, Cupples LA, Haines JL, et al. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease: a meta-analysis: APOE and Alzheimer Disease Meta Analysis Consortium. JAMA 1997;278:1349-1356. (Pubitemid 27449696)
30. van Duijn CM, de Knijff P, Cruts M, et al. Apolipoprotein E4 allele in a population-based study of early-onset Alzheimer's disease. Nat Genet 1994;7:74-78. (Pubitemid 24232384)
31. van der Flier WM, Schoonenboom SN, Pijnenburg YA, Fox NC, Scheltens P. The effect of APOE genotype on clinical phenotype in Alzheimer disease. Neurology 2006; 67:526-527. (Pubitemid 44214991)
32. Schott JM, Ridha BH, Crutch SJ, et al. Apolipoprotein e genotype modifies the phenotype of Alzheimer disease. Arch Neurol 2006;63:155-156. (Pubitemid 43063881)